Moderate ischemic mitral regurgitation in ischemic heart disease: to operate or not? A meta-analysis

Razan A Alsuayri1, Abdullah K Alassiri2, Ahmed K Awad3

  • 1Batterjee Medical College for Sciences and Technology, Jeddah, Saudi Arabia.

Insights

For ischemic mitral regurgitation, combining coronary artery bypass grafting (CABG) with mitral valve repair (MVR) showed no significant difference in one-year mortality, stroke, or heart failure hospitalization compared to CABG alone. Personalized treatment is key.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Research

Background:

  • Ischemic mitral regurgitation is common in patients with coronary artery disease.
  • The decision between coronary artery bypass grafting (CABG) alone or with mitral valve repair for ischemic mitral regurgitation is challenging.
  • Unfavorable outcomes have been linked to ischemic mitral regurgitation post-CABG, but the benefit of concurrent mitral valve repair remains unclear.

Purpose of the Study:

  • To systematically review and meta-analyze clinical outcomes comparing CABG alone versus CABG with mitral valve surgery.
  • To determine if combining CABG with mitral valve repair improves results over CABG alone for ischemic mitral regurgitation.

Main Methods:

  • Systematic review and meta-analysis of six randomized clinical trials.
  • Searched PubMed and Google Scholar for studies comparing CABG versus CABG with mitral valve replacement (MVR).
  • Analyzed data from 852 patients.

Main Results:

  • No significant differences were found between CABG alone and CABG+MVR regarding one-year mortality, stroke, atrial fibrillation, or heart failure hospitalization.
  • A trend towards higher risk of recurrent/residual mitral regurgitation was observed with CABG+MVR (RR=5.42, P=0.065), with significant heterogeneity (I²=66%).
  • No significant heterogeneity was identified for other major outcomes.

Conclusions:

  • CABG alone and CABG+MVR yielded similar clinical results in the studied population.
  • The findings emphasize the necessity for individualized treatment strategies in managing ischemic mitral regurgitation.
  • Patient-specific factors should guide the decision between isolated CABG and combined CABG with MVR.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
947
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
606
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598